Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $9.76 in the prior trading day, Regenxbio Inc (NASDAQ: RGNX) closed at $7.92, down -18.85%. In other words, the price has decreased by -$18.85 from its previous closing price. On the day, 2.09 million shares were traded.
Ratios:
Our goal is to gain a better understanding of RGNX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.69 and its Current Ratio is at 2.69. In the meantime, Its Debt-to-Equity ratio is 0.55 whereas as Long-Term Debt/Eq ratio is at 0.38.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Neutral and sets its target price to $14 from $38 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 30 ’24 when VITTAL VASISTA bought 20,041 shares for $7.41 per share.
KARABELAS ARGERIS N sold 10,000 shares of RGNX for $101,052 on Oct 01 ’24. The Director now owns 11,286 shares after completing the transaction at $10.11 per share. On Sep 03 ’24, another insider, KARABELAS ARGERIS N, who serves as the Director of the company, sold 10,000 shares for $11.56 each. As a result, the insider received 115,588 and left with 11,286 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.76 while its Price-to-Book (P/B) ratio in mrq is 1.51.
Stock Price History:
Over the past 52 weeks, RGNX has reached a high of $17.35, while it has fallen to a 52-week low of $5.03. The 50-Day Moving Average of the stock is 8.38%, while the 200-Day Moving Average is calculated to be -14.92%.
Shares Statistics:
A total of 49.55M shares are outstanding, with a floating share count of 45.21M. Insiders hold about 9.79% of the company’s shares, while institutions hold 85.71% stake in the company.
